Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00302809 · ClinicalTrials.gov registry record · NA
Blood Pressure Lowering Effects of Grape Juice
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00302809 is a NA study that has completed, run by Boston University. The registered enrollment target is 60 participants.
The verdict
NCT00302809, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Recent studies suggest that a diet rich in fruit and vegetables can lower blood pressure, and a number of lines of evidence suggest that grape products may have such an effect. The purpose of this study is to determine whether consuming grape juice lowers blood pressure in individuals with pre-hypertension or stage I hypertension.
Interventions
- DIETARY_SUPPLEMENT Concord Grape Juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00302809
The ClinicalTrials.gov registry entry for NCT00302809 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Concord Grape Juice is the first listed.
NCT00302809 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00302809 about?
NCT00302809 is a clinical study titled "Blood Pressure Lowering Effects of Grape Juice". Recent studies suggest that a diet rich in fruit and vegetables can lower blood pressure, and a number of lines of evidence suggest that grape products may have such an effect. The purpose of this study is to determine whether consuming grape juice lowers blood pressure in individuals with pre-hyper...
What is the current status of trial NCT00302809?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2006-03. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00302809?
The interventions under investigation include: Concord Grape Juice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00302809?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.